Investment Strategy Investment Case Related news Financing
2019-10-14
Guoqian Venture Capital Regional Service Center walks into Italy-2018/…

On October 11, Beijing time, Dr. Hao Chen, a partner of Guoqian Venture Capital, participated in the finals of the 2018/2019 Sino-Italian Innovation and Entrepreneurship Competition in the field of biomedicine as an expert review.

2019-09-11
Guoqian Venture Capital Helped to Build Code Biology to Receive Angel …

Suzhou Dianma Biological Technology Co., Ltd. (referred to as "Dianma Biological") announced to the outside that it has received an angel round of over ten million yuan in financing.

2019-04-17
Johns Hopkins & Guoqian Venture Capital China-US Innovation Summit

On April 14th, Beijing time, the 2019 Johns Hopkins China-US Innovation Summit ended successfully at Johns Hopkins University in Baltimore, Maryland. GQ Ventures served as the domestic branch of the summit and the second phase of 2019 overseas Cross-border video roadsho…

2019-04-12
Guoqian Venture Capital helped Guoke Junhao complete the first round o…

Suzhou Guoke Junhao Biotechnology Co., Ltd. ("Guoke Junhao" for short) announced to the outside that it has obtained 10 million yuan of Pre-A round of financing from Guoqian Venture Capital Management (Suzhou) Co., Ltd. ("Guoqian Venture Capital") .

2019-03-30
Perfect ending | 2019 Qianqian Venture Capital's first cross-borde…

On March 29, the "China Science and Technology Association (Suzhou) Overseas Talent Offshore Innovation and Entrepreneurship Base Regional Service Center Roadshow and 2019 Guoqian Venture Capital's first overseas cross-border roadshow" was successfully held in…

2019-01-25
The development track of Guoqian's invested projects in 2018

Guoqian Venture Capital Management (Suzhou) Co., Ltd. (hereinafter referred to as Guoqian Venture Capital) was established on March 3, 2017, and the first private equity fund was established in July 2017-Suzhou Guoqian Medical Venture Capital Enterprise (Limited Partner…

Total:18Previous123NextPage:2/3